Literature DB >> 8412389

Hospital drug formularies and use of hospital services.

F A Sloan1, G S Gordon, D L Cocks.   

Abstract

Many hospitals have introduced formularies to reduce hospital pharmacy expense, among other reasons. This study provides empirical evidence of the influence of hospital formulary restrictions on pharmacy charges, all other hospital charges, and on length of stay, using a survey of hospital drug policies and hospital discharge data from Washington State in 1989. Limiting the number of drugs in particular therapeutic categories reduced total charges incurred for gastrointestinal disease and asthma patients, increased total charges for cardiovascular disease patients, and had no effect on charges for infectious diseases patients. Restricting availability of drugs reduced pharmacy charges, but these savings tended to be offset by increases in other charges. Combining the categories, we found that restricting availability of drugs did not affect charges. We conclude that across-the-board restrictions do not result in cost savings, although savings may be realized for particular drug categories.

Entities:  

Mesh:

Year:  1993        PMID: 8412389     DOI: 10.1097/00005650-199310000-00001

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  10 in total

1.  Rational pharmacotherapy in The Netherlands: formulary management in Dutch hospitals.

Authors:  R Fijn; L T de Jong-van den Berg; J R Brouwers
Journal:  Pharm World Sci       Date:  1999-04

2.  Changing doctor prescribing behaviour.

Authors:  P S Gill; M Mäkelä; K M Vermeulen; N Freemantle; G Ryan; C Bond; T Thorsen; F M Haaijer-Ruskamp
Journal:  Pharm World Sci       Date:  1999-08

3.  Drug and Therapeutics (D & T) committees in Dutch hospitals: a nation-wide survey of structure, activities, and drug selection procedures.

Authors:  R Fijn; J R Brouwers; R J Knaap; L T De Jong-Van Den Berg
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

4.  The quality of Dutch hospital drug formularies: evaluation of technical features and organisational information.

Authors:  R Fijn; C S de Vries; S A Engels; J R Brouwers; C J de Blaey; L T de Jong-van den Berg
Journal:  Pharm World Sci       Date:  1999-06

5.  Determinants of HMO formulary adoption decisions.

Authors:  David Dranove; Edward F X Hughes; Mark Shanley
Journal:  Health Serv Res       Date:  2003-02       Impact factor: 3.402

6.  The formulary decision-making process in a health maintenance organisation setting.

Authors:  M D Shepherd; R D Salzman
Journal:  Pharmacoeconomics       Date:  1994-01       Impact factor: 4.981

Review 7.  Constraints on antidepressant prescribing and principles of cost-effective antidepressant use. Part 1: Depression and its treatment.

Authors:  J A Henry; C A Rivas
Journal:  Pharmacoeconomics       Date:  1997-05       Impact factor: 4.981

8.  Impact of a formulary change in proton pump inhibitors on health care costs and patients' symptoms.

Authors:  D W Raisch; L M Klaurens; C Hayden; I Malagon; G Pulliam; R Fass
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

Review 9.  Pharmaceutical care versus traditional drug treatment. Is there a difference?

Authors:  C D Hepler; T J Grainger-Rousseau
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

10.  Health services research: what is being done, why do it at all?

Authors:  E G Jessop
Journal:  Postgrad Med J       Date:  1994-10       Impact factor: 2.401

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.